|
Feb 29
|
Anaptys to Present at TD Cowen’s 44th Annual Health Care Conference and 2024 AAD Annual Meeting
|
|
Feb 28
|
AnaptysBio, Inc. (ANAB) Expected to Beat Earnings Estimates: Should You Buy?
|
|
Jan 31
|
Anaptys to Present at Guggenheim’s 6th Annual Biotechnology Conference
|
|
Jan 13
|
AnaptysBio Inc CEO Daniel Faga Sells 6,866 Shares
|
|
Jan 9
|
Sarepta (SRPT) Rises on Solid Q4 and 2023 Preliminary Results
|
|
Jan 9
|
Corcept (CORT) Stock Rises on Upbeat Revenue Guidance for 2024
|
|
Jan 8
|
Are Medical Stocks Lagging Acadia Healthcare (ACHC) This Year?
|
|
Dec 27
|
AnaptysBio (NASDAQ:ANAB) shareholders have endured a 66% loss from investing in the stock five years ago
|
|
Dec 7
|
Does AnaptysBio, Inc. (ANAB) Have the Potential to Rally 69.36% as Wall Street Analysts Expect?
|
|
Nov 27
|
Anaptys Expands Immune Cell Modulator Pipeline with Exclusive License to BDCA2 Modulator Antibody Portfolio from Centessa Pharmaceuticals
|
|
Nov 16
|
Revenue Downgrade: Here's What Analysts Forecast For AnaptysBio, Inc. (NASDAQ:ANAB)
|
|
Nov 14
|
Down -24.46% in 4 Weeks, Here's Why AnaptysBio, Inc. (ANAB) Looks Ripe for a Turnaround
|
|
Aug 7
|
AnaptysBio Announces Second Quarter 2023 Financial Results and Provides Business Update
|
|
Apr 27
|
Cytokinetics (CYTK) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
|
|
Apr 26
|
Will AnaptysBio, Inc. (ANAB) Report Negative Q1 Earnings? What You Should Know
|